Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University
Fred Hutchinson Cancer Center
Istituto Clinico Humanitas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bambino Gesù Hospital and Research Institute
Fudan University
National Cancer Institute (NCI)
Heidelberg University
Samsung Medical Center